about
Trypanosoma cruzi: Entry into Mammalian Host Cells and Parasitophorous Vacuole FormationControl and management of congenital Chagas disease in Europe and other non-endemic countries: current policies and practicesChagas disease and transfusion medicine: a perspective from non-endemic countriesMammalian cellular culture models of Trypanosoma cruzi infection: a review of the published literatureSystems Biology Approach to Model the Life Cycle of Trypanosoma cruziSoulamarin isolated from Calophyllum brasiliense (Clusiaceae) induces plasma membrane permeabilization of Trypanosoma cruzi and mytochondrial dysfunctionA quinoxaline derivative as a potent chemotherapeutic agent, alone or in combination with benznidazole, against Trypanosoma cruziTrypanosomiasis-induced megacolon illustrates how myenteric neurons modulate the risk for colon cancer in rats and humansSimvastatin and Benznidazole-Mediated Prevention of Trypanosoma cruzi-Induced Endothelial Activation: Role of 15-epi-lipoxin A4 in the Action of SimvastatinA Novel Trypanosoma cruzi Protein Associated to the Flagellar Pocket of Replicative Stages and Involved in Parasite GrowthNeglect of a Neglected Disease in Italy: The Challenge of Access-to-Care for Chagas Disease in Bergamo AreaQuality of Reporting and Adherence to ARRIVE Guidelines in Animal Studies for Chagas Disease Preclinical Drug Research: A Systematic ReviewValidation of N-myristoyltransferase as Potential Chemotherapeutic Target in Mammal-Dwelling Stages of Trypanosoma cruziIncreased mortality attributed to Chagas disease: a systematic review and meta-analysis.Genetic Polymorphisms of IL17 and Chagas Disease in the South and Southeast of BrazilA synthetic peptide from Trypanosoma cruzi mucin-like associated surface protein as candidate for a vaccine against Chagas diseaseThe evolution of trypanosomatid taxonomy.Omega-3 supplementation on inflammatory markers in patients with chronic Chagas cardiomyopathy: a randomized clinical study.In vitro and in vivo studies of the biological activity of novel arylimidamides against Trypanosoma cruziPotential therapeutic use of herbal extracts in trypanosomiasis.Acute Chagas disease induces cerebral microvasculopathy in miceSelecting suitable solid organ transplant donors: Reducing the risk of donor-transmitted infectionsInduction of IL-12 production in human peripheral monocytes by Trypanosoma cruzi Is mediated by glycosylphosphatidylinositol-anchored mucin-like glycoproteins and potentiated by IFN- γ and CD40-CD40L interactions.Comparison of seven diagnostic tests to detect Trypanosoma cruzi infection in patients in chronic phase of Chagas disease.Megazol and its bioisostere 4H-1,2,4-triazole: comparing the trypanocidal, cytotoxic and genotoxic activities and their in vitro and in silico interactions with the Trypanosoma brucei nitroreductase enzyme.Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment.Activities of psilostachyin A and cynaropicrin against Trypanosoma cruzi in vitro and in vivo.Peripheral nervous system manifestations of infectious diseasesEffects of omega-3 polyunsaturated fatty acid supplementation in patients with chronic chagasic cardiomyopathy: study protocol for a randomized controlled trial.A clinical adverse drug reaction prediction model for patients with chagas disease treated with benznidazoleRecombinant yellow fever viruses elicit CD8+ T cell responses and protective immunity against Trypanosoma cruziProfile of Trypanosoma cruzi infection in a tropical medicine reference center, Northern ItalyHow to improve the early diagnosis of Trypanosoma cruzi infection: relationship between validated conventional diagnosis and quantitative DNA amplification in congenitally infected childrenProliferation and differentiation of Trypanosoma cruzi inside its vector have a new trigger: redox status.Cytokine profiling in Chagas disease: towards understanding the association with infecting Trypanosoma cruzi discrete typing units (a BENEFIT TRIAL sub-study).Follow-up of an asymptomatic Chagas disease population of children after treatment with nifurtimox (Lampit) in a sylvatic endemic transmission area of Colombia.Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversityTrypanosoma cruzi Epimastigotes Are Able to Manage Internal Cholesterol Levels under Nutritional Lipid Stress Conditions.MicroRNA Transcriptome Profiling in Heart of Trypanosoma cruzi-Infected Mice: Parasitological and Cardiological OutcomesA novel ABCG-like transporter of Trypanosoma cruzi is involved in natural resistance to benznidazole
P2860
Q21131212-467C00FD-F427-4180-951F-8737A0474BBBQ26765133-AAB64F84-D017-46D2-8B9D-A0CA94F354E2Q26777968-15C50EE8-E9C9-40F4-A8D5-8DBB72441591Q27026878-033C94F8-461F-4364-A5B3-8C7788B743CAQ27330520-BA90F808-DB88-40A8-9E89-DCBE3ED90024Q28536088-4E0A13F0-6B57-4C1F-AE38-7F3CB85F2F04Q28538813-84F624B2-6A1F-40C3-ADA3-9AD71FDB4BB2Q28546487-29EDD11C-13A6-4769-97FD-7D873E29CC53Q28547300-41CD1B37-237D-442B-A78B-DA72DADF875FQ28548459-B71DB2EC-F3A5-466E-89D8-693658DD9BB0Q28548478-433B20BB-66EF-43C6-9C13-A14E3A3E9A1EQ28551079-4854F0D8-91F8-46D4-9322-1E6435FEE520Q28551708-A080C239-CD66-4C8B-9FAF-D52A9DA77467Q30383896-DC980205-D8AF-4134-84D2-2C71A7F4E276Q33567136-67476A25-4BE0-4103-AA43-0C9D0D289CD0Q33760119-DF8FD344-4ACE-41CF-88A8-E85B75B9BFEDQ33776260-2C58F6EF-0D33-44E9-8F01-F1F37D1BE9D0Q33785166-A1BD94ED-959F-4FAC-AAEB-89E93D494746Q33798362-F847C29F-9ED4-480C-8174-AC67657B1217Q33850850-AB278246-D851-4D93-8FCF-6B045E7C9BC3Q33881623-EFA7EC3C-1607-4A24-B843-CDADDD4036A7Q33891744-7C91A7AD-C676-49DB-B4B3-DFEEC7724673Q33997924-CB26F54F-0684-42D1-BF27-C4495EB781E7Q34009737-7F606AE3-AE93-4A91-A3A8-7E97EF2B237FQ34040586-1399011C-2DEB-4031-BB8E-33CA01AE8027Q34297640-220651D2-9348-4873-B53F-6A6D4ABCDD79Q34363646-52F38E8A-724F-4030-A855-07856D8D9D01Q34418510-2B685A95-9CA2-4873-BE41-7079D841A732Q34478887-6D995383-749F-48C4-91A8-8266E6B9044BQ34596630-1C0BAF69-11CC-471A-BA7D-B87113A662E3Q34635043-4AE8859E-7D30-4291-AF88-E1D1251A9AC6Q34679944-CEC90B34-164D-4E92-946A-D80361A57C65Q35023669-8F510EA5-4CFA-4CC8-A99B-8D030C03D51AQ35073631-FF6D0BF2-1CEE-43FB-8627-447ED3B8D226Q35114499-CE55FDAD-2DFB-4118-AEA0-A65F847EFFA3Q35130398-1BBACF06-630A-4585-A66C-AD7B1A167D06Q35333873-EA28F125-D5AB-4DD9-9321-52BBCFD3199DQ35661767-DB4BC5D7-681E-46C6-ADE9-C80B5DE407DCQ35667175-FEDAB980-728F-43AF-B459-8E0519582A8DQ35810796-F7F79E5A-3988-4B09-903D-5177AC09E0E8
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
American trypanosomiasis (Chagas disease).
@ast
American trypanosomiasis (Chagas disease).
@en
type
label
American trypanosomiasis (Chagas disease).
@ast
American trypanosomiasis (Chagas disease).
@en
prefLabel
American trypanosomiasis (Chagas disease).
@ast
American trypanosomiasis (Chagas disease).
@en
P2093
P1476
American trypanosomiasis (Chagas disease).
@en
P2093
Anis Rassi
Joffre Marcondes de Rezende
P304
P356
10.1016/J.IDC.2012.03.002
P5008
P577
2012-06-01T00:00:00Z